{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:17:11Z","timestamp":1791148631378,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T00:00:00Z","timestamp":1244764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00253-009-2064-y","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T11:35:12Z","timestamp":1244720112000},"page":"53-63","source":"Crossref","is-referenced-by-count":40,"title":["A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor"],"prefix":"10.1007","volume":"85","author":[{"given":"Samia","family":"Rourou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"van der Ark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Majoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiny","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9la","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,12]]},"reference":[{"key":"2064_CR1","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1021\/bp000110+","volume":"16","author":"M Butler","year":"2000","unstructured":"Butler M, Burgener A, Patrick M, Berry M, Moffatt D, Huzel N, Barnab\u00e9 N, Coombs K (2000) Application of a serum-free medium for the growth of Vero cells and the production of Reovirus. Biotechnol Prog 16:854\u2013858","journal-title":"Biotechnol Prog"},{"key":"2064_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0167-7799(00)01474-8","volume":"18","author":"Y Chisti","year":"2000","unstructured":"Chisti Y (2000) Animal-cell damage in sparged bioreactors. Tibtech 18:420\u2013432","journal-title":"Tibtech"},{"key":"2064_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0958-1669(00)00197-X","volume":"12","author":"L Chu","year":"2001","unstructured":"Chu L, Robinson DK (2001) Industrial choices for protein production by large scale cell culture. Curr Opin Biotechnol 12:180\u2013187","journal-title":"Curr Opin Biotechnol"},{"key":"2064_CR4","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.1016\/j.vaccine.2007.09.043","volume":"25","author":"WA Costa","year":"2007","unstructured":"Costa WA, Cunha RS, Boltzan VL, Silva ACR, Caporale GMM, Chaves LB, Oselka GWO, Juunqueira DA, Panachao MRI, Dias RA, Takaoka NY (2007) Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium. Vaccine 25:8140\u20138145","journal-title":"Vaccine"},{"key":"2064_CR5","first-page":"221","volume-title":"Biological safety; principals and practices","author":"O Doblhoff-Dier","year":"2000","unstructured":"Doblhoff-Dier O, Stacey G (2000) Cell lines: applications and biosafety. In: Fleming DO, Hunt DL (eds) Biological safety; principals and practices, 3rd edn. ASM, Washington, pp 221\u2013239","edition":"3"},{"key":"2064_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.vaccine.2004.06.014","volume":"23","author":"NM Frazatti-Gallina","year":"2004","unstructured":"Frazatti-Gallina NM, Mourao-Fuches RM, Paoli RL, Silva MLN, Miyaki C, Valentini EJG (2004) Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23:511\u2013517","journal-title":"Vaccine"},{"key":"2064_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0168-1656(01)00362-5","volume":"92","author":"NM Frazatti-Gallina","year":"2001","unstructured":"Frazatti-Gallina NM, Paoli RL, Moura-Fuches RM, Jorge SC, Pereira CA (2001) Higher production of rabies virus in serum-free medium cell cultures on microcarriers. J Biotechnol 92:67\u201372","journal-title":"J Biotechnol"},{"key":"2064_CR8","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1016\/j.vaccine.2006.01.019","volume":"24","author":"Y Genzel","year":"2006","unstructured":"Genzel Y, Fischer M, Reichl U (2006a) Serum-free influenza virus production avoiding washing step and medium exchange in large-scale microcarrrier culture. Vaccine 24:3261\u20133272","journal-title":"Vaccine"},{"key":"2064_CR9","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1016\/j.vaccine.2006.05.023","volume":"24","author":"Y Genzel","year":"2006","unstructured":"Genzel Y, Olmer RM, Sch\u00e4fer B, Reichl U (2006b) Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Vaccine 24:6074\u20136087","journal-title":"Vaccine"},{"key":"2064_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0167-7799(99)01420-1","volume":"8","author":"F Hesse","year":"2000","unstructured":"Hesse F, Wagner R (2000) Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. Tibtech 8:173\u2013180","journal-title":"Tibtech"},{"key":"2064_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1023\/A:1008133717035","volume":"33","author":"DW Jayme","year":"2000","unstructured":"Jayme DW, Smith SR (2000) Media formulation options and manufacturing process controls to safeguard against introduction of animal origin contaminants in animal cell culture. Cytotechnol 33:27\u201336","journal-title":"Cytotechnol"},{"issue":"5","key":"2064_CR12","first-page":"360","volume":"83","author":"DL Knobel","year":"2005","unstructured":"Knobel DL, Cleaveland S, Coleman PG, F\u00e8vre EM, Meltzer M, Miranda ME (2005) Reevaluating the burden of rabies in Africa and Asia. Bull WHO 83(5):360\u2013368","journal-title":"Bull WHO"},{"key":"2064_CR13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.micinf.2005.03.034","volume":"7","author":"AAP Kumar","year":"2005","unstructured":"Kumar AAP, Mani KR, Palaniappan C, Bhau LNR, Swaminathan K (2005) Purification, potency and immunogenicity analysis of Vero cell culture-derived rabies vaccine: a comparative study of single-step chromatography and zonal centrifuge purification. Microbes Infect 7:1110\u20131116","journal-title":"Microbes Infect"},{"key":"2064_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1021\/bp025568l","volume":"19","author":"K Landauer","year":"2003","unstructured":"Landauer K, Wiederkum S, D\u00fcrrschmid M, Klug H, Simic C, Bl\u00fcml G, Doblhoff-Dier O (2003) Influence of carboxymethyl dextran and ferric citrate on the adhesion of CHO cells on microcarriers. Biotechnol Prog 19:21\u201329","journal-title":"Biotechnol Prog"},{"key":"2064_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.vaccine.2006.06.083","volume":"25","author":"CC Liu","year":"2007","unstructured":"Liu CC, Lian WC, Butler M, Wu SC (2007) High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 25:19\u201324","journal-title":"Vaccine"},{"key":"2064_CR16","first-page":"15","volume":"99","author":"AS Lubiniecki","year":"1999","unstructured":"Lubiniecki AS (1999) Elimination of serum from cell culture medium. Dev Biol Stand 99:15\u201356","journal-title":"Dev Biol Stand"},{"key":"2064_CR17","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.vaccine.2005.08.109","volume":"24","author":"I Marcelino","year":"2006","unstructured":"Marcelino I, Sousa MFQ, V\u00e9rissimo C, Cunha AE, Carrondo MJT, Alves PM (2006) Process development for the mass production of Ehrlichia ruminantium. Vaccine 24:1716\u20131725","journal-title":"Vaccine"},{"key":"2064_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1008021317639","volume":"30","author":"OW Merten","year":"1999","unstructured":"Merten OW, Kallel H, Manuguerra JC, Tardy-Panit M, Crainic R, Delpeyroux F (1999) The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses. Cytotechnol 30:191\u2013201","journal-title":"Cytotechnol"},{"key":"2064_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF00772195","volume":"14","author":"OW Merten","year":"1994","unstructured":"Merten OW, Kierulff JV, Castignolles N, Perrin P (1994) Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines. Cytotechnol 14:47\u201359","journal-title":"Cytotechnol"},{"key":"2064_CR20","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.vaccine.2005.07.114","volume":"24","author":"M Mochizuki","year":"2004","unstructured":"Mochizuki M (2004) Growth characteristics of canine pathogenic viruses in MDCK cells cultured in RPMI 1640 medium without animal protein. Vaccine 24:1744\u20131748","journal-title":"Vaccine"},{"key":"2064_CR21","first-page":"285","volume-title":"Laboratory techniques in rabies","author":"B Montagnon","year":"1996","unstructured":"Montagnon B, Fanget B (1996) Purified Vero cell vaccine for humans. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies. WHO, Geneva, pp 285\u2013289"},{"key":"2064_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0264-410X(93)90343-V","volume":"11","author":"S Morgeaux","year":"1993","unstructured":"Morgeaux S, Tordo N, Gontier C, Perrin P (1993) \u03b2-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus. Vaccine 11:82\u201390","journal-title":"Vaccine"},{"key":"2064_CR23","first-page":"113","volume":"96","author":"J O\u2019Connor","year":"1998","unstructured":"O\u2019Connor J (1998) rtPA is a well-characterized protein. Dev Biol Stand 96:113\u2013121","journal-title":"Dev Biol Stand"},{"key":"2064_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.biologicals.2008.06.004","volume":"36","author":"J Petricciani","year":"2008","unstructured":"Petricciani J, Sheets R (2008) An overview of animal cell substrates for biological products. Biologicals 36:359\u2013362","journal-title":"Biologicals"},{"key":"2064_CR25","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.vaccine.2007.01.086","volume":"25","author":"S Rourou","year":"2007","unstructured":"Rourou S, Van der Ark A, Van der Velden T, Kallel H (2007) A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 25:3879\u20133889","journal-title":"Vaccine"},{"key":"2064_CR26","doi-asserted-by":"crossref","unstructured":"Rourou S, Van der Ark A, Van der Velden T, Kallel H (2009) Development of an animal component free medium for Vero cells culture. Biotechnol Prog, In press","DOI":"10.1002\/btpr.279"},{"key":"2064_CR27","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1016\/j.vaccine.2008.03.077","volume":"26","author":"AC Silva","year":"2008","unstructured":"Silva AC, Delgado I, Sousa MFQ, Carrondo MJT, Alves PM (2008) Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine. Vaccine 26:3305\u20133311","journal-title":"Vaccine"},{"key":"2064_CR28","first-page":"354","volume-title":"Laboratory techniques in rabies","author":"JS Smith","year":"1973","unstructured":"Smith JS, Yager PA, Baer GM (1973) A rapid tissue culture test for determining rabies neutralizing antibody. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies. WHO, Geneva, pp 354\u2013357"},{"key":"2064_CR29","first-page":"3","volume":"125","author":"N Tordo","year":"2006","unstructured":"Tordo N, Bahloul C, Jacob Y, Jallet C, Perrin P, Badrane H (2006) Rabies: epidemiological tendencies and control tools. Dev Biol Stand 125:3\u201313","journal-title":"Dev Biol Stand"},{"key":"2064_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.biologicals.2007.02.002","volume":"35","author":"H Toriniwa","year":"2007","unstructured":"Toriniwa H, Komiya T (2007) Japanese encephalitis virus production in Vero cells with serum-free-medium using a novel oscillating bioreactor. Biologicals 35:221\u2013226","journal-title":"Biologicals"},{"key":"2064_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.enzmictec.2004.11.008","volume":"36","author":"K Trabelsi","year":"2005","unstructured":"Trabelsi K, Rourou S, Loukil H, Majoul S, Kallel H (2005) Comparison of various culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor. Enzyme Microb Technol 36:514\u2013519","journal-title":"Enzyme Microb Technol"},{"key":"2064_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jbiotec.2005.07.018","volume":"121","author":"K Trabelsi","year":"2006","unstructured":"Trabelsi K, Rourou S, Loukil H, Majoul S, Kallel H (2006) Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J Biotechnol 121:261\u2013271","journal-title":"J Biotechnol"},{"key":"2064_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0167-7799(98)01209-8","volume":"16","author":"L Pol Van der","year":"1998","unstructured":"Van der Pol L, Tramper J (1998) Shear sensitivity of animal cells from a culture medium perspective. Tibtech 16:323\u2013328","journal-title":"Tibtech"},{"key":"2064_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00749935","volume":"13","author":"J Varani","year":"1993","unstructured":"Varani J, Inman DR, Fligiel SEG, Hillegas WJ (1993) Use of recombinant and synthetic peptides as attachment factors for cells on micocarriers. Cytotechnol 13:89\u201398","journal-title":"Cytotechnol"},{"key":"2064_CR35","first-page":"360","volume-title":"Laboratory techniques in rabies","author":"LA Wilbur","year":"1996","unstructured":"Wilbur LA, Aubert MFA (1996) The NIH test for potency. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies. WHO, Geneva, pp 360\u2013368"},{"key":"2064_CR36","unstructured":"World Health Organisation (2005) WHO expert consultation rabies: first report. WHO Technical Report Series, No. 931. Geneva: WHO, p13"},{"key":"2064_CR37","first-page":"425","volume":"82","author":"World Health Organisation position paper","year":"2007","unstructured":"World Health Organisation position paper (2007) World Health Organisation 82:425\u2013436","journal-title":"World Health Organisation"},{"key":"2064_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1021\/bp010120q","volume":"18","author":"SC Wu","year":"2002","unstructured":"Wu SC, Hung YL (2002) Stationary and microcarrier cell culture process for propagating Japanese Encephalitis Virus. Biotechnol Prog 18:124\u2013128","journal-title":"Biotechnol Prog"},{"key":"2064_CR39","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1016\/j.vaccine.2004.05.037","volume":"22","author":"SC Wu","year":"2004","unstructured":"Wu SC, Liu CC, Lian WC (2004) Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22:3858\u20133864","journal-title":"Vaccine"},{"key":"2064_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/bit.10917","volume":"85","author":"AY Yokomizo","year":"2004","unstructured":"Yokomizo AY, Antoniazzi MM, Galdino PL, JrN A, Jorge SAC, Pereira CA (2004) Rabies virus production in high Vero cell density cultures on macroporous microcarriers. Biotechnol Bioeng 85:506\u2013515","journal-title":"Biotechnol Bioeng"},{"key":"2064_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10616-006-9030-7","volume":"51","author":"HI Yuk","year":"2006","unstructured":"Yuk HI, Lin GB, Ju H, Sifi I, Lam Y, Cortez A, Liebertz D, Berry MJ, Schwartz RM (2006) A serum free Vero production platform for a chimeric virus vaccine candidate. Cytotechnol 51:183\u201392","journal-title":"Cytotechnol"},{"key":"2064_CR42","unstructured":"Zeng S Bogner, FM, Kunert R, Mueller D, Unterluggauer F (2005) Cell culture process. WO Patent N\u00b0 2005069979"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-009-2064-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-009-2064-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-009-2064-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-009-2064-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:04:51Z","timestamp":1583870691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-009-2064-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1007\/s00253-009-2064-y","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,12]]}}}